Acquisition of Omrix Biopharmaceuticals by Johnson & Johnson
Is a
Acquired Company
Acquirer
Acquisition Amount (USD)
432,740,000
Date Announced
November 23, 2008
Find more entities like Acquisition of Omrix Biopharmaceuticals by Johnson & Johnson
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.